Oldest pages
From Glioblastoma Treatments
Jump to navigationJump to search
Showing below up to 46 results in range #51 to #96.
- CCNU (Lomustine) (00:21, 18 January 2025)
- BCNU (Carmustine) and Gliadel (Carmustine Wafers) (00:22, 18 January 2025)
- Platinum Compounds (00:22, 18 January 2025)
- Procarbazine (00:22, 18 January 2025)
- Bevacizumab (Avastin) (00:22, 18 January 2025)
- Gleevec (Imatinib) (00:22, 18 January 2025)
- Angiotensin-II Receptor Blockers (ARB) (00:23, 18 January 2025)
- VT-122 (00:23, 18 January 2025)
- Letrozole (00:23, 18 January 2025)
- Silibinin (an ingredient in Milk Thistle) (00:24, 18 January 2025)
- Chloroquine and Hydroxychloroquine (00:24, 18 January 2025)
- EGFR inhibitors: Iressa, Tarceva, and Erbitux (gefitinib, erlotinib, and (00:24, 18 January 2025)
- Optune (00:24, 18 January 2025)
- Proton Radiation Therapy (00:25, 18 January 2025)
- Radiation via Monoclonal Antibodies (00:25, 18 January 2025)
- Gamma Knife Radiosurgery (00:25, 18 January 2025)
- Next-Generation CAR T-Cell Therapy for GBM (00:25, 18 January 2025)
- VAL-083 (Dianhydrogalactitol) (00:26, 18 January 2025)
- BCNU (Carmustine) (00:26, 18 January 2025)
- Fotemustine (00:26, 18 January 2025)
- Carboplatin (00:26, 18 January 2025)
- CPT-11 (Irinotecan) (00:27, 18 January 2025)
- Dendritic Cell Vaccine (DCVax-L) (00:27, 18 January 2025)
- Agenus Prophage (Heat-Shock Protein Peptide Complex-96) Vaccine (00:27, 18 January 2025)
- ICT-107 (00:27, 18 January 2025)
- SL-701 (00:27, 18 January 2025)
- Anti-CMV Dendritic Cell Vaccine (00:28, 18 January 2025)
- Rindopepimut (CDX-110) (00:28, 18 January 2025)
- Wilms Tumor 1 (WT1) Peptide Vaccine (00:28, 18 January 2025)
- Genetically modified Poliovirus (PVS-RIPO) (00:28, 18 January 2025)
- DNX-2401 adenovirus (00:29, 18 January 2025)
- Newcastle Disease Virus (00:29, 18 January 2025)
- Herpes Virus (00:29, 18 January 2025)
- Beta-blockers (especially propranolol) and the role of the sympathetic (00:29, 18 January 2025)
- Resveratrol (00:30, 18 January 2025)
- Sulforaphane (00:30, 18 January 2025)
- Metformin (00:30, 18 January 2025)
- Parthenolide (00:30, 18 January 2025)
- Chronotherapy (00:31, 18 January 2025)
- Hyperthermia (00:31, 18 January 2025)
- Metronomic low dose temozolomide (TMZ) (00:31, 18 January 2025)
- Anlotinib (00:31, 18 January 2025)
- COC protocol (18:46, 23 February 2025)
- MN-166 (18:58, 23 February 2025)
- Temozolomide (19:52, 8 March 2025)
- TTF (20:08, 8 March 2025)
